Lunit will participate in a Groundbreaking Prospective Study to Validate AI Performance
Will AI Identify Breast Cancer Better Than Radiologists in Actual Clinical Screening?
A research team at the Karolinska Institutet in Sweden will assess the performance of AI startup Lunit s breast cancer AI software as an independent mammography reader in screening
The prospective study marks first of its kind, aiming to screen 55,000 women with mammography at Capio Sankt Gorans Hospital in Stockholm, Sweden
SEOUL, South Korea, April 8, 2021 /PRNewswire/ Lunit, a leading medical AI startup, today announced that it will participate in the new study conducted by the research team of Karolinska Institutet in Sweden. According to Lunit, this research is the first prospective study in Europe to validate the performance of AI in an actual clinical trial of screening mammography.